Literature DB >> 743486

Differential arginine dependence and the selective cytotoxic effects of activated macrophages for malignant cells in vitro.

G A Currie, C Basham.   

Abstract

Normal and neoplastic cells from 4 species (man, rat, mouse and hamster) were examined for their dependence on exogenous L-arginine in tissue culture. The malignant cells required a higher concentration of L-arginine in the medium than their normal counterparts (with similar doubling times) to maintain optimal proliferation. Complete arginine deprivation resulted in equal growth inhibition of normal and malignant cells, but more rapid cytolysis of the malignant cell. Deprivation of L-arginine, followed 24 h later by rescue with L-arginine, allowed normal cells to proliferate, but the reproductive capacity of the malignant cells was irreversibly impaired. Since the cytotoxic activity of LPS-activated macrophages was associated with the release of arginase and was abrogated by excess L-arginine, it is suggested that the biological basis for the selective effects of such macrophages may reside in the L-arginine dependence of the target cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 743486      PMCID: PMC2009827          DOI: 10.1038/bjc.1978.270

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

Review 1.  Mechanisms by which activated macrophages inhibit lymphocyte responses.

Authors:  A C Allison
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

2.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Selective lethal effect of thymidine on human and mouse tumor cells.

Authors:  S S Lee; B C Giovanella; J S Stehlin
Journal:  J Cell Physiol       Date:  1977-09       Impact factor: 6.384

4.  Effect of arginine deprivation on macromolecular processes in Burkitt's lymphoblasts.

Authors:  A Weinberg; Y Becker
Journal:  Exp Cell Res       Date:  1970-06       Impact factor: 3.905

5.  Activated macrophages kill tumour cells by releasing arginase.

Authors:  G A Currie
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

6.  The heterogeneity of arginases in rat tissues.

Authors:  A Herzfeld; S M Raper
Journal:  Biochem J       Date:  1976-02-01       Impact factor: 3.857

7.  Activated macrophages release a factor which lyses malignant cells but not normal cells.

Authors:  G A Currie; C Basham
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

8.  Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts.

Authors:  M S Simberkoff; G J Thorbecke; L Thomas
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  Suppression of in vitro cytotoxic response by macrophages due to induced arginase.

Authors:  J T Kung; S B Brooks; J P Jakway; L L Leonard; D W Talmage
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Continued initiation of DNA synthesis in arginine-deprived Chinese hamster ovary cells.

Authors:  A S Weissfeld; H Rouse
Journal:  J Cell Biol       Date:  1977-04       Impact factor: 10.539

View more
  13 in total

1.  Partial purification of a liver-derived tumor cell growth inhibitor that differentially inhibits poorly-liver metastasizing cell lines: identification as an active subunit of arginase.

Authors:  P G Cavanaugh; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Retinoids as regulators of macrophage function.

Authors:  J Rhodes; S Oliver
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

Review 3.  Arginine catabolism, liver extracts and cancer.

Authors:  Denys N Wheatley; Elaine Campbell
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

4.  Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF.

Authors:  Y Ichinose; J Y Tsao; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro.

Authors:  C D Bucana; L C Hoyer; A J Schroit; E Kleinerman; I J Fidler
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

6.  Comparative efficacy of liposomes containing synthetic bacterial cell wall analogues for tumoricidal activation of monocytes and macrophages.

Authors:  T Utsugi; A Nii; D Fan; C C Pak; Y Denkins; P van Hoogevest; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Quantitative studies of natural immunity to solid tumours in rats. The nature of the killer cell depends on the type of assay.

Authors:  C G Brooks; G R Flannery; P J Webb; R W Baldwin
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

8.  Augmentation of spontaneous macrophage-mediated cytolysis by eosinophil peroxidase.

Authors:  C F Nathan; S J Klebanoff
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

9.  Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions.

Authors:  V H Freedman; T E Gorrell; C F Nathan; C S Copeland; S C Silverstein
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

10.  Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1981-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.